The myth of affordability - Australia’s medicines debate is really about the choices we make

In the current budget year, the Australian government is expected to spend roughly $780 billion. Around $125 billion will go to healthcare. Within this enormous envelope, however, the amount allocated to innovative medicines is vanishingly small. This reflects a choice that is consistently misrepresented as an affordability challenge. Affordability is the consequence of the choice, not a reason. …